Use of SPM to Measure Adhesion Forces: Some Pharmaceutical Applications. Frank M. Etzler

Similar documents
The influence of lactose particle size on dry powder inhalation performance

Novel drug delivery system. Nanos-in-Micros

Respiratory. Martin Jetzer DDL27 Edinburgh December 2016

SUMMARY AND CONCLUSION

The unlocked synergy of DFE Pharma MCC

COMPARISON OF THE RESPIRABLE FRACTION FROM THREE DIFERENT DPI DEVICES

LubriTose Mannitol Michael Crowley, Director of R&D, Excipients

AFM SURFACE ANALYSIS OF FUNGAL MODIFIED CTMP FIBERS

KING KHALID UNIVERSITY

REVISION OF MONOGRAPH ON TABLETS. Tablets

Re-compaction properties of lactose and microcrystalline cellulose

Table 1. Coating Parameters

Quantification of the Surface Morphologies of Lactose Carriers and Their Effect on the in Vitro Deposition of Salbutamol Sulphate

How do you use the AiM Vascular Mapping Kit?

Spray-Drying Formulation + Process Development Advances

HARD TWO-PIECE HPMC CAPSULES FOR PHARMACEUTICAL APPLICATIONS IN INHALATION

A matter of timing. ensure optimal delivery for acid-sensitive products. capsugel.com

PHARMACEUTICAL AID PREPARED BY B.KIRUTHIGA LECTURER DEPT OF PHARMACEUTICAL CHEMISTRY

Rationale of and Experience with the Expert System

Kolliwax HCO. Technical Information. Hydrogenated castor oil powder for pharmaceutical use. = Registered trademark in many countries.

CAPSULE-BASED DRY POWDER INHALERS, AN OPTIMAL SOLUTION FOR DIFFERENT INSPIRATIONAL RATES

FORMULATION DEVELOPMENT - A QbD Approach to Develop Extended Release Softgels

Formulation Considerations for Inhaled Products

TEPZZ _7584 A_T EP A1 (19) (11) EP A1 (12) EUROPEAN PATENT APPLICATION. (51) Int Cl.: A61K 9/00 ( ) A61K 31/439 (2006.

Understanding cascade impaction and its importance for inhaler testing

Molecular Cartography:

905 UNIFORMITY OF DOSAGE UNITS

CHAPTER-I DRUG CHARACTERIZATION & DOSAGE FORMS

Ensuring the Quality of Some Drug-Device Combination Products - FDA Perspective

OCE TABLETING DIRECT COMPRESSION CO-PROCESSED LACTOSE. Technical brochure MicroceLac 100

Figure 1: SEM Mannogem EZ (1000x)

STARCH Application Data

Challenges in Developing Stable and Efficient Probiotic Formulations

Influence of blender type on the performance of ternary dry powder inhaler formulations

CONSIDERATION OF THE END USER AND THE LIMITATIONS DURING THE ORAL ADMINISTRATION DRUG DESIGN: CHALLENGE IN DIFFERENT AGE GROUPS

Use of Math Modelling to Understand Delivery of Biopharmaceutical Molecules to the Lung

nubiola Zn free pigments: How they work Dr. Ricard March Nubiola

Innovations in Design: NIA-West. Missy Lowery, MSc Head of Integrated Marketing Capsugel, now a Lonza company 11/13/2017

Novel Application of an Old Excipient L-Leucine- Improving Physical and. Aerosolization Stability of Spray Dried Amorphous DPI Formulations.

FLAVOUR FLOW & ADHESION

IPAC-RS/UF Orlando Inhalation Conference March 20, S.T. Horhota 1, C.B. Verkleij 2, P.J.G. Cornelissen 2, L. Bour 3, A. Sharma 3, M.

Appendix M: Device Technique

Applications of capsule dosing techniques for use in dry powder inhalers

Cell Membranes, Epithelial Barriers and Drug Absorption p. 1 Introduction p. 2 The Plasma Membrane p. 2 The phospholipid bilayer p.

The Kinetics of De-agglomeration of Magnesium Stearate Dry-Coated Salbutamol Sulphate Powders

Identification of crystalline forms suitable for inhalation in drug discovery

Pelagia Research Library

Citation for published version (APA): Westerman, E. M. (2009). Studies on antibiotic aerosols for inhalation in cystic fibrosis s.n.

Rapid Quantitative Analysis of Cannabidiol from Consumer Products Using UltraPerformance Convergence Chromatography

Assessment of Human Pharmaceutical Products Registered in Kenya by Route of Administration and Type of Dosage Form

PREPARATION AND EVALUATION OF STARCH - PEG 1500 CO-PROCESSED EXCIPIENT AS A NEW DIRECTLY COMPRESSIBLE VEHICLE IN TABLET FORMULATIONS

Designed and manufactured specifically for pharmaceutical capsule filling

6. SR, XR, CR, and TR are examples of formulations. A) oral B) modified release C) repeat action D) soft gels

FORMULATION AND DEVELOPMENT OF ER METOPROLAOL SUCCINATE TABLETS

Available online Research Article

Effect of Rise in Simulated Inspiratory Flow Rate and Carrier Particle Size on Powder Emptying From Dry Powder Inhalers

INSTRUCTIONS FOR USE AND CARE

The binding performance of DFE Pharma Starch

Protection and Processing of a Highly Hygroscopic Herbal Extract by Drug Layering and Film Coating

YOUR ORAL SOLID DOSE. In pursuit of excipient excellence

The use of a novel optical technology, the VariDose, was also investigated in order to obtain a system which can lead to an effective and efficient

Excipient Considerations for Continuous Manufacturing Implementation

Rail CRC Project R3-105

Shades: A1, A2, A3, A3.5, A4, B1, B2, B3, C2, C3, C4, D3, DB, OA2, OA3, OA3.5, OB2, Incisal, SL,SLO, SLT, YB

Case Study 1: Pharmaceutical Development of EXUBERA

Achieving Optimal Particle Size Distribution in Inhalation Therapy

AEROSOL THERAPY: THE PRACTICALITIES

Formulation and evaluation of immediate release salbutamol sulphate

CSPA AEROSOL GUIDE NINTH EDITION TABLE OF CONTENTS. SECTION B INTRODUCTION: CSPA Aerosol Products Division Committees

University of Groningen. Optimisation of dry powder inhalation de Boer, Anne

A New Shadowgraphic Imaging Method for the Suspension Stability Analysis of Pressurized Metered Dose Inhalers

EFFECT OF ZnO NANOPARTICLES ON CURE BEHAVIOR OF THE EPDM RUBBER

Journal of Chemical and Pharmaceutical Research

USP Chewable Gels Monographs

Using an Inhaler and Nebulizer

COMMITTEE FOR MEDICINAL PRODUCTS FOR HUMAN USE (CHMP) GUIDELINE ON THE PHARMACEUTICAL QUALITY OF INHALATION AND NASAL PRODUCTS

Challenges in Nonclinical Development of Inhalation Drug Products

Improved Inspection of Composite Wind Turbine Blades with Accessible Advanced Ultrasonic Phased Array Technology

Ketac Universal Aplicap

The Soft Gel Specialist

PREMIXES FOR MEDICATED FEEDING STUFFS FOR VETERINARY USE. Praeadmixta ad alimenta medicata ad usum veterinarium. Effervescent powders

DVA Symposium Mexico City Anisul Quadir Ph.D, MBA SE Tylose USA, Inc. (A Shin-Etsu Chemical Group Co.) Totowa, NJ

Metered Dose Inhaler Technology

STARCH Proven and Trusted Excipient for Performance and Versatility EXCIPIENTS. Effective and economical disintegrant

Innovation in formulations to improve aerosol delivery

040716_ANDI_VENTIS WEBSITE(new) Printout 1. HOME PAGE. Welcome to our world of Dry Powder Inhalers!

European Medicines Agency decision

PHARMACEUTICS I صيدالنيات 1 UNIT 1 INTRODUCTION

Technical brochure InhaLac

RDD Europe 2009 Workshop

Influence of elasticity on the syneresis properties of κ-carrageenan gels

VIVAPHARM PVP/VA. Copovidone, Ph.Eur. USP/NF, JPE, E. The Ultimate Tablet Binder for All Processing Technologies

International Journal of Research in Pharmaceutical and Nano Sciences Journal homepage:

Risk Assessment for coating applications

LIPOSOME STABILITY VERIFICATION BY ATOMIC FORCE MICROSCOPY

Lactose Free, Direct Compression Formulation Used to Produce Loratadine (10 mg) Tablets

Pulmonary deposition of inhaled drugs

Pharmaceutical Preparation For Internal Use

Application of Starches, Modified Starches and Starch Derivatives in Pharmaceutical Products

Research Article. *Corresponding author Mahesh M.Giri

Transcription:

Use of SPM to Measure Adhesion Forces: Some Pharmaceutical Applications Frank M. Etzler

Particle Adhesion in Pharmaceutical Science Particle adhesion important to a number of areas of interest. Adhesion science has received relatively little attention by pharmaceutical scientists. Particle adhesion related to: Powder flow Powder mixing Powder dispersion in Dry Powder aerosol devices Tablet hardness

Powder Dispersion in Dry Powder Inhalation Devices Problem: Dry powders can inhaled directly for pulmonary delivery of drugs. A constant amount of particles in the range of 2-5μm must be delivered to the lung. Variable adhesion between components results in variable drug delivery.

Principles of Adhesion W a =γ 1 + γ 2 - γ 12 W a =W a LW +W a AB vogc W a AB =2 (γ 1 + γ 2- ) 1/2 + 2 (γ 1 - γ 2+ ) ½ Fowkes W = f N ΔH AB a f = 1 lnwa lnt AB 1 AB a AB * H KDN a KAN d Δ = +

Particle Size and Adhesion For sphere-sphere and sphere-plane interactions: London - van der Waals Forces: Fr () r Electrical: Fr () r 2 3 1 Fr () Coulomb: 2 r Capillary: F() r r(1 r x ) x> 1 Zimon, A.D. Adhesion of Dust and Powder, 2 nd ed. 1982.

SPM to Measure Adhesion Forces Colloidal Probe

Adhesion Force Curve approach Cantilever Deflection (a.u.) Δz Δz retraction Distance(a.u.)

Adhesion Mapping Gelatin Capsules a b Adhesion maps (10 x 10 μm scan): (a) adhesion and (b) adhesion area map of a capsule. c d (c) adhesion and (d) adhesion area map of capsule after extraction process.

vocg Acid Base Parameters of Gelatin Capsules 2.5 Surface Free Energy (mn/m) 2 1.5 1 0.5 Gamma B Gamma A Extracted 0 c12363 24465 27984 27985 27986 27987 c94840 51301 51501 351A51 BOR1 CMR BOR2 PEG 2 Capsugel Su Heung PEG Plasticized Gamma B Normal Surface Free Energy (mn/m) 1.5 1 0.5 Gamma A 0 c12363 24465 27985 27986 27987 51301 Capsule Lot

Contamination of Capsule Affects Adhesion F ad / d particle (nn/μm) 60 40 20 72601 Pyrole Acrylic Acid acetylene C6F14 Mother Lot 29625 ext TOF-SIMS shows surface contamination of capsules with SDS. Some mold release components are unextractable 0 29623 29625 0.6 0.7 0.8 0.9 1 1.1 % S+P

Lactose Surface Imaging SPM phase image of a surface of a single particle of lactose (1x1μm). Dark area represents a thin layer of contaminating material. White specks are another surface contaminant.

Lactose Surface Chemistry and Capsule Adhesion

Surface Contamination of Lactose CH vs OCO ESCA suggests partial coverage of lactose with aliphatic containing materials. SIMS confirms ESCA results. Acidic surfaces are more contaminated

Lactose Gelatin Adhesion Adhesion Force (nn) 500 400 300 200 100 0 Pext 29625ext 72601 29623 P 29625 0 4 8 12 16 Particle diameter (μm) Adhesion force of Pharmatose 200M vs colloidal probe diameter. Linear relation indicates that interaction is primarily via London - van der Waals forces.

Relative Adhesion of Drug and Lactose on Capsules Lactose Adhesion Force (nn) 240 200 160 120 80 PEGext 29625ext 72601 29625 PEG 160 200 240 280 320 360 400 IBr Adhesion Force (nn) 29623 Normalized Adhesion Force (nn/μm) 100 80 60 40 20 0 Drug-Drug Lact-Lact Lact-Drug Drug-Cap Lact-Cap Drug-CC Lact-CC F N = F exp d

SPM in Tablet Making Punch Sticking 80 Fe Coated Tip Drug Interactions Adhesion Force (nn) 60 40 20 Iboprofen Ketoprofen Fe Flubiprofen 0 Wang et al. J. Pharm Sci 92(4) 798 2003 Wang et al. J. Pharm Sci. 92(4),798 (2003) 0 2000 4000 6000 8000 W AD (nn/nm)

Effect of Humidity on Particle Adhesion Force measurements taken using blank AFM tips against compressed disks of SEDS and micronized salbutamol. (a) Flexible contact tip against micronised salbutamol (b) Flexible contact tip against SEDS salbutamol (c) Stiffer tapping tip against micronized salbutamol (d) Stiffer tapping tip against SEDS salbutamol Pharmaceutical Research, Vol. 21, No. 6, June 2004 ( 2004)

Friction on Steel J. Lee / International Journal of Pharmaceutics 340 (2007) 191 197

Take Home Message SPM can be a useful tool in pharmaceutical applications. Several applications to inhalation formulations have been published. SPM can help determine the surface chemical purity of surfaces. SPM can be used to understand the relative adhesion between materials. Other surface chemical methods (e.g. IGC) can be used successfully with SPM to enhance understanding. Further application to pharmaceutical science appears to be promising.